are more stable, many individuals in our field mistakenly think that inhibiting SMC migration
and proliferation is a viable therapeutic strategy for reducing plaque rupture. Therefore, it is
critical to recognize that lesional SMC may have either atheroprotective or atheropromoting
properties depending on the nature of their phenotypic transitions10 and we currently know
little about what controls these respective transitions.